Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Experts Call for Urgent Action on Psychedelic Access in Canada

June 15, 2026 at 09:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

VANCOUVER, BC – TheNewswire – June 15, 2026 - In April 2026, MAPS Canada convened the first-ever National Dialogue on Access to Psychedelics, bringing together clinicians, researchers, policymakers, Indigenous knowledge holders, legal experts, community and business leaders, advocates, and people with lived experience to examine the future of psychedelic access in Canada.

The dialogue comes at a pivotal moment. Growing evidence supports the potential of psychedelic-assisted therapies for conditions including post-traumatic stress disorder (PTSD), depression, substance use disorders, and end-of-life distress. At the same time, public interest and demand for these treatments continue to increase - as do recent and upcoming legislative proposals signalling growing political attention to this emerging field.

Despite this momentum, access to psychedelic therapies in Canada remains limited and fragmented. Existing pathways are narrow, inconsistent, and often inaccessible to those who may benefit. Meanwhile, significant psychedelic use continues outside formal healthcare and regulatory systems.

Today, MAPS Canada released an Executive Summary highlighting key findings, priority areas, and calls to action emerging from the National Dialogue. The summary is intended to inform ongoing discussions and policy development ahead of the release of the full report.

“The National Dialogue made clear that Canadians are seeking safe, equitable access to psychedelic therapies. We now have an opportunity to move beyond fragmented pathways and work toward a more coordinated, evidence-informed approach.”

— Rielle Capler, Executive Director, MAPS Canada

Executive Summary: https://www.mapscanada.org/wp-content/uploads/2026/06/Executive-Summary_Toward-a-Framework-for-Psychedelic-Access_FINAL.pdf

Media Contact

Rielle Capler
Executive Director, MAPS Canada
rielle@mapscanada.org

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article